Gene Therapy

Gene Therapy

You will be surprised to know that through gene therapy a number of agonising and debilitating diseases will be pushed into history! Gene therapy involves changing the genetic information in a cell. For the ease of understanding genes, let me explain all the terms with relation to one another in a human cell.  

Cells contain a nucleus, which is the controlling center of the cell. Nucleus contains chromosomes. Chromosomes are made up of genes, which in turn are made up of Deoxyribonucleic acid (DNA). Changes in the composition of DNA are very important in determining the expression of a gene. We talk about variant SARS Coronavirus, otherwise called mutation, causing Kent, South African and Indian variants of Covid-19. During mutation, there will be a deletion or addition of a nucleic acid, in the case of SARS coronavirus, it is Ribonucleic acid (RNA).

Gene therapy is intended  to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use. Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work in several ways; 
1)It replaces a disease causing gene with a healthy copy of the gene.
2) It inactivates a disease causing gene that is not functioning properly.
3)It introduces a new or modified gene to treat a disease.

Gene therapy techniques are used to treat diseases including cancer, genetic diseases, and infectious diseases. Gene Therapy Products (GTP) are biological products regulated by Centre for Biologic Evaluation and Research (CBER) of Food and Drug Administration (FDA) of America. Gene therapy products are the following;

1)Plasmid DNA, a circular DNA molecule which can be genetically engineered to carry therapeutic genes into human cells.

2)Viral Vectors, have a natural ability to deliver genetic materials into cells (that is how SARS coronavirus multiply in human cell), and therefore some gene therapy products are derived from viruses. Once viruses have been modified to remove their ability to cause infectious disease, these can be used as vehicles to carry therapeutic genes into human cells.

3)Bacterial Vectors, can be modified to prevent them from causing infectious diseases and then used as  vehicles to carry therapeutic genes to human tissues.

4)Human gene editing technology is a method by which  editing disrupts harmful genes or repairs mutated genes.

5)Patient Derived Cellular Gene Therapy Products is a technique in which cells are removed from patients and modified through viral vectors and then returned to patients.  

blog-1620941370external-content.duckduckgo.com (1).jpg

There are stringent government regulations on initiating and developing gene therapy in most developed countries. First gene approved therapy was performed on a four year old child in September 1990 to treat a genetic defect that left her with a severe immune deficiency. Since then it was  done on body cells for diseases like Cystic Fibrosis, Familial Hypercholesterolemia, cancer, and severe combined immunodeficiency (SCID). Marketing a gene therapy product requires submission and approval by a Biologics License Application (BLA).

If you search on the internet, you will find laboratories offering gene therapy at a cost.  There are monogenic disorders, like Cystic Fibrosis, Familial Hypercholesterolemia, and severe combined immunodeficiency (SCID), sickle cell anaemia, hemophilia, Duchenne Muscular Dystrophy, Parkinson’s Disease, Huntington’s Disease, chronic granulomatous disease, Fanconi’s Disease, Alpha-1 antitrypsin deficiency and Gaucher’s disease. In these diseases, the defective gene is in a single locus, and the diseases are 100% inherited. Nowadays many of these diseases with single locus defect, can be treated.

There are genetic diseases in which multiple loci are involved. In this category, diseases like diabetes, heart disease, cancers, schizophrenia and Alzheimer’s disease, and infections like human immunodeficiency virus disease (HIV) are included. Some of them are associated with unhealthy lifestyle. By genetic analysis (mapping of genes), it is easy to determine whether someone is likely to get  the inherited disease. While I was practising two years ago, the representatives of genetic analysis companies were approaching me for promoting their business. By mapping genes, we can find out who is likely to get a single locus or multi loci genetic disease. Research is being carried out to edit multiple gene defects and then to cure or improve the disease process. 

I shall explain step by step the process of treating haemophilia through gene therapy. Haemophilia is an inherited condition, in which the patient is having a deficiency of factor 8 required for clotting. Patients with haemophilia suffer from bleeding disorder on a minor cut or tooth extraction. The treatment for haemophilia is called  Roctavian treatment.  In Roctavian therapy, recombinant technology of adeno virus vector is used.  Roctavian is a modified gene, which is introduced into adeno virus. This is then administered intravenously to the haemophilia patient. 

Virus vector (vehicle) has the inherent capacity to transfer its genetic material into the host cell, in this case platelets. Once inside the platelet, the modified genetic material multiplies exponentially and instructs the tissues to manufacture factor 8 clotting factor. The study shows,  there is more than a 90% decrease in annual bleeding rate and more than 90% decrease in factor VIII use,  3 years after having received an effective dose of gene therapy. The Food and Drug Agency of America (FDA) will be shortly approving treating haemophilia with gene therapy.

Gene therapy cannot be administered on the second time as it invokes antigen-antibody reaction. Other side effects of gene therapy include enlargement of liver and allergy. However, its benefits immensely outweigh the side effects. It is refreshing to note that in coming years, more and more diseases will be amenable to gene therapy. Let us hope the devastating misery of diseases like Duchenne Muscular Dystrophy, Alzheimer’s, Parkinson’s and schizophrenia will be diseases of the bygone days.

Share On
image
Dr. C.J.GEORGE FRCS

This blog is about my experience as a doctor working in various countries in different clinical set up. This experience spans through 45 years, in which I acquired a lot of favourable contacts and unfavourable encounters. I shall dig deep into them and make it interesting to the readers. Unlike others in the profession, I worked as a community medical officer in a remote areas, prison medical officer, benefit service medical officer, in cardiac surgery in prestigious institutions and as a private doctor. I was managing my own businesses, and real estate in three continents. I hope the information I impart will be valuable to the like minded readers.

Related Post

Comment Form